tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
US Market

Ultragenyx Pharmaceutical (RARE) Cash flow

Compare
796 Followers

Ultragenyx Pharmaceutical Cash Flow

RARE's free cash flow for Q3 2024 was $-68.61M. For the 2024 fiscal year, RARE's free cash flow was decreased by $5.01M and operating cash flow was $-67.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -474.81M$ -380.46M$ -338.69M$ -132.22M$ -345.38M
Investing Cash Flow
$ 168.00M$ -291.65M$ -195.37M$ -179.12M$ -13.04M
Financing Cash Flow
$ 388.14M$ 501.21M$ 118.55M$ 600.27M$ 679.31M
End Cash Position
$ 219.40M$ 137.60M$ 309.58M$ 726.29M$ 436.24M
Free Cash Flow
$ -521.57M$ -526.59M$ -411.79M$ -176.13M$ -370.21M
Currency in USD

Ultragenyx Pharmaceutical Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis